IQVIA Holdings Inc (IQV)

133.01
NYSE
Prev Close 133.01
Day Low/High 0.00 / 0.00
52 Wk Low/High 91.57 / 146.10
Exchange NYSE
Shares Outstanding 197.61B
Market Cap 26.28B
Div & Yield N.A. (N.A)

Latest News

IQVIA Announces Pricing Of Secondary Public Offering

IQVIA Announces Pricing Of Secondary Public Offering

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) announced today the pricing of an underwritten, secondary public offering of 5,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC and investment...

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 5,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC and investment...

IQVIA Launches E360 Genomics

IQVIA Launches E360 Genomics

IQVIA™ (NYSE: IQV) today announced the launch of a patented technology platform that advances real-world research and protects genomic data privacy.

IQVIA's FluSTAR Online Dynamic Platform Helps Consumers Track Local Rates Of Flu, Allergy And Asthma

IQVIA's FluSTAR Online Dynamic Platform Helps Consumers Track Local Rates Of Flu, Allergy And Asthma

IQVIA™ (NYSE:IQV), a leader in human data science, provides consumers with quick and easy access to seasonal suffering data, giving them unique insights into important health related information.

IQVIA To Present At The Barclays Global Healthcare Conference On March 12, 2019

IQVIA To Present At The Barclays Global Healthcare Conference On March 12, 2019

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), announced today that Michael McDonnell, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2019 at 1:35 p.

Carol J. Burt Joins IQVIA Board Of Directors

Carol J. Burt Joins IQVIA Board Of Directors

IQVIA™ (NYSE:IQV) today announced the appointment of Carol J. Burt to its board of directors, effective today.

Noteworthy Thursday Option Activity: IQV, MOV, ACIA

Noteworthy Thursday Option Activity: IQV, MOV, ACIA

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in IQVIA Holdings Inc , where a total volume of 8,609 contracts has been traded thus far today, a contract volume which is representative of approximately 860,900 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 78.4% of IQV's average daily trading volume over the past month, of 1.1 million shares.

IQVIA Reports Fourth-Quarter And Full-Year 2018 Results, Issues First-Quarter And Full-Year 2019 Guidance

IQVIA Reports Fourth-Quarter And Full-Year 2018 Results, Issues First-Quarter And Full-Year 2019 Guidance

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter and year ended December 31,...

IQVIA Introduces RIM Smart, The Industry's First Fully Integrated, End-to-End Regulatory Information Management System

IQVIA Introduces RIM Smart, The Industry's First Fully Integrated, End-to-End Regulatory Information Management System

IQVIA™ (NYSE:IQV) today announced the launch of IQVIA RIM Smart, the first fully integrated, cloud-based, end-to-end regulatory information management solution for life sciences.

Analyst Favorites With Strong Buyback Activity: IQVIA Holdings Ranks As A Top Pick

Analyst Favorites With Strong Buyback Activity: IQVIA Holdings Ranks As A Top Pick

A study of analyst recommendations at the major brokerages shows that IQVIA Holdings Inc is the #21 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

IQVIA Launches IQVIA Biotech, Dedicated To Emerging Biotech And Biopharma Industry

IQVIA Launches IQVIA Biotech, Dedicated To Emerging Biotech And Biopharma Industry

IQVIA™ (NYSE:IQV) today announced the launch of IQVIA™ Biotech and its new approach to delivering tailored clinical and commercial solutions for small biotech and biopharma companies.

IQVIA Launches Next Generation Site Portal Technology Capabilities To Streamline Clinical Trial Communications

IQVIA Launches Next Generation Site Portal Technology Capabilities To Streamline Clinical Trial Communications

IQVIA™ (NYSE:IQV) today launched two new capabilities to support clinical teams more easily and quickly share cross-trial training materials and safety notifications.

IQVIA To Announce Fourth-Quarter And Full-Year 2018 Results And Issue 2019 Guidance On February 14, 2019

IQVIA To Announce Fourth-Quarter And Full-Year 2018 Results And Issue 2019 Guidance On February 14, 2019

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), will announce its fourth-quarter and full-year 2018 financial results and issue 2019 guidance before the market opens on Thursday, February 14, 2019.

IQVIA Institute For Human Data Science Study: Global Medicine Spending Exceeds $1.5 Trillion By 2023 As Spending Growth Steadies

IQVIA Institute For Human Data Science Study: Global Medicine Spending Exceeds $1.5 Trillion By 2023 As Spending Growth Steadies

Total spending on medicines is expected to top $1.5 trillion by 2023, up 50 percent from 2014, even as annual growth moderates at 3-6 percent on an annual compound basis compared to 6.

IQVIA Named To FORTUNE's 2019 List Of "World's Most Admired Companies"

IQVIA Named To FORTUNE's 2019 List Of "World's Most Admired Companies"

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) has once again been named to FORTUNE magazine's "World's Most Admired Companies" list.

IQVIA Announces Comprehensive Multi-Tenant SaaS Safety Platform For Life Sciences Industry

IQVIA Announces Comprehensive Multi-Tenant SaaS Safety Platform For Life Sciences Industry

IQVIA™ (NYSE:IQV) today announced its development of a Software as a Service (SaaS) safety platform that scales to address the drug safety and surveillance challenges of life sciences organizations, ranging from emerging biopharma to large pharmaceutical...

IQVIA's Orchestrated Customer Engagement (OCE) Solution Adopted By More Than 30 Life Sciences Companies In First Year Of Launch

IQVIA's Orchestrated Customer Engagement (OCE) Solution Adopted By More Than 30 Life Sciences Companies In First Year Of Launch

IQVIA™ (NYSE:IQV) today announced that more than 30 life sciences companies have selected Orchestrated Customer Engagement (OCE) as their commercial solution in the 12 months since the groundbreaking technology first launched.

IQVIA Named Best Contract Research Organization Full-Service Provider In 2018 Scrip Awards

IQVIA Named Best Contract Research Organization Full-Service Provider In 2018 Scrip Awards

IQVIA™ (NYSE:IQV) today announced that it was awarded the 2018 Scrip Award for Best Contract Research Organization — Full-Service Provider.

IQVIA Announces Pricing Of Secondary Public Offering

IQVIA Announces Pricing Of Secondary Public Offering

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) announced today the pricing of an underwritten, secondary public offering of 6,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment...

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 6,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment...

IQVIA's OCE Technology Platform Selected By Napo Pharmaceuticals To Increase Commercial Efficiency

IQVIA's OCE Technology Platform Selected By Napo Pharmaceuticals To Increase Commercial Efficiency

IQVIA™ (NYSE:IQV) today announced that Napo Pharmaceuticals, Inc. (Napo), a wholly-owned subsidiary of Jaguar Health, Inc.

IQVIA Holdings Becomes #121 Most Shorted S&P 500 Component, Replacing NextEra Energy

IQVIA Holdings Becomes #121 Most Shorted S&P 500 Component, Replacing NextEra Energy

The most recent short interest data has been released for the 11/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

IQVIA's Orchestrated Customer Engagement Selected By Novo Nordisk International Operations

IQVIA's Orchestrated Customer Engagement Selected By Novo Nordisk International Operations

IQVIA™ (NYSE:IQV) today announced that Novo Nordisk, a global healthcare company with nearly a century of innovation and leadership in diabetes care, has selected IQVIA's market-leading Orchestrated Customer Engagement platform for deployment across Novo...

Adhera Therapeutics Selects IQVIA's OCE Technology Platform To Support Commercial Excellence

Adhera Therapeutics Selects IQVIA's OCE Technology Platform To Support Commercial Excellence

IQVIA™ (NYSE:IQV) today announced that Adhera Therapeutics Inc. (OTCQB:ATRX) has selected Orchestrated Customer Engagement (OCE), IQVIA Technologies' transformational commercial platform, to build its commercial infrastructure and bring the company's...

See How IQVIA Holdings Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How IQVIA Holdings Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that IQVIA Holdings Inc is the #16 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

IQVIA Launches Digital ICF Author, A SaaS EConsent Tool To Transform The Informed Consent Process

IQVIA Launches Digital ICF Author, A SaaS EConsent Tool To Transform The Informed Consent Process

IQVIA™ (NYSE:IQV) announced today the launch of Informed Consent Form (ICF) Author, a SaaS eConsent tool for use in clinical trials.

IQVIA To Present At The Credit Suisse Annual Healthcare Conference On November 13, 2018

IQVIA To Present At The Credit Suisse Annual Healthcare Conference On November 13, 2018

IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), announced today that Michael McDonnell, executive vice president and chief financial officer, will speak at the Credit Suisse 27th Annual Healthcare Conference in Scottsdale, AZ on Tuesday, November 13, 2018 at...

IQVIA Holdings Becomes #192 Most Shorted S&P 500 Component, Replacing Illinois Tool Works

IQVIA Holdings Becomes #192 Most Shorted S&P 500 Component, Replacing Illinois Tool Works

The most recent short interest data has been released for the 10/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

TheStreet Quant Rating: B (Buy)